In vitro evaluation of anticoagulant therapy management when urgent percutaneous coronary intervention is required in rivaroxaban-treated patients.

Autor: Melek M; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey., Ari H; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey. hasanari03@yahoo.com., Ari S; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey., Cilgin MC; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey., Yarar M; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey., Huysal K; Department of Biochemistry, Bursa Postgraduate Hospital, Bursa, Turkey., Ağca FV; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey., Bozat T; Department of Cardiology, Bursa Postgraduate Hospital, Bursa, Turkey.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2023 Nov; Vol. 396 (11), pp. 3221-3232. Date of Electronic Publication: 2023 May 20.